HeyJaredCrystal Gwizdala
- Indexed articles, last 90 days
- 2
- Latest publication
- Sep 15, 2026
- Outlet visibility, for Yale School of Medicine
- Top 500K sites
- Earliest in this view
- Aug 17, 2026
Latest articles
Who Benefits Most from Glucose Monitoring Devices? (opens the original)
Read excerpt
In 2024, continuous glucose monitoring devices hit the shelves for over-the-counter consumer use. Historically, these devices were prescribed for people with type 1 diabetes and, more recently, for those with type 2 diabetes to monitor their glucose levels and adjust insulin dosage. Now, the devices are generating interest in people with prediabetes, obesity, or other conditions, including otherwise healthy people with an interest in wellness. As health tech becomes more common and users gather
Can GLP-1s Help People Stop Insulin? (opens the original)
Read excerpt
A new study led by Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology and metabolism) at Yale School of Medicine, examined the impact of Glucagon-like Peptide-1 Receptor Agonist (GLP-1) therapy on rates of insulin discontinuation in people with type 2 diabetes compared with other oral medications typically prescribed to help manage blood sugar levels. The findings were published in Annals of Internal Medicine. While insulin therapy is an effective treatment for many individual
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Yale School of Medicine, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.